NEA Management Company’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,925,287
Closed -$66.2M 57
2022
Q4
$66.2M Hold
5,925,287
3.72% 9
2022
Q3
$33.3M Hold
5,925,287
1.66% 19
2022
Q2
$25.7M Hold
5,925,287
1.32% 19
2022
Q1
$69M Hold
5,925,287
1.99% 12
2021
Q4
$108M Hold
5,925,287
2.19% 9
2021
Q3
$70.2M Hold
5,925,287
0.83% 16
2021
Q2
$102M Hold
5,925,287
1.33% 11
2021
Q1
$108M Hold
5,925,287
2.43% 8
2020
Q4
$112M Hold
5,925,287
2.94% 10
2020
Q3
$125M Hold
5,925,287
5.3% 5
2020
Q2
$171M Hold
5,925,287
6.88% 3
2020
Q1
$207M Hold
5,925,287
10.84% 2
2019
Q4
$145M Buy
+5,925,287
New +$104M 6.85% 4

Other funds holding OYST

NEA Management Company's OYST Position: Q1 2023 in Review

NEA Management Company sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 5,925,287 shares — an estimated $66.2M sold.

NEA Management Company first reported a position in OYST in Q4 2019 and held it in 13 quarters. The position peaked at $207M in Q1 2020. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • NEA Management Company reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • NEA Management Company sold 5,925,287 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $66.2M.
  • NEA Management Company first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 13 quarters.
  • NEA Management Company's Oyster Point Pharma, Inc. Common Stock position peaked at $207M in Q1 2020.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on NEA Management Company's 13F filing for Q1 2023, filed 15 May 2023.